Robert W. Yeh MD, MSc, MBA, FACC, FSCAI
Director, Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center; Professor of Medicine, Harvard Medical School, Boston, Massachusetts,Dr. Robert W. Yeh is the Katz-Silver Family Professor of Medicine in the Field of Cardiovascular Outcomes Research at Harvard Medical School and Director of the Richard A. and Susan F. Smith Center for Outcomes Research at the Beth Israel Deaconess Medical Center. His area of investigation focuses on 1) applying innovative methods to evaluate new cardiovascular devices and therapies in both clinical trials and observational studies, with an emphasis on understanding methods to improve the value of novel technologies as they are used in clinical practice, and 2) examining the impacts of health policies on medical decision making and patient outcomes. He is a standing member of the Circulatory Devices Advisory Panel for the US Food and Drug Administration.
Disclosures
Dr. Yeh reports grants and consulting fees from Abbott Vascular, Boston Scientific, and Medtronic.
Recent Contributions to PracticeUpdate:
- Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis
- The DOAC Score for Patients With AF on Direct-Acting Oral Anticoagulants
- Improved Hospital Readmission Rate Through Clinical Interventions After PCI
- 6- vs 24-Month DAPT After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin
- Impact of Clinical Presentation in Patients on 6- or 24-Month DAPT After Stent Implantation
- A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After Percutaneous Coronary Intervention